Clinical trials
Placenta clinical trials
Below are recruiting placenta clinical trials, each written for real people, not researchers. We’re tracking 46 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03626844Recruiting
Manual placenta removal after birth study
This study looks at how removing the placenta by hand after a normal vaginal birth may affect the mother. It may help doctors better manage this common procedure.
NazarethAges 18–45 - NCT06493799RecruitingPhase 3
Injectable placenta extract for fatty liver disease
This trial tests an injectable medication made from human placenta to see if it can improve liver health in people with fatty liver disease (from alcohol or other causes). It may help lower liver enzyme levels and reduce liver damage.
Yongin-siAges 19–70 - NCT07412925Recruiting
Tourniquet for placenta accreta in C-section
This study tests a safe method using a tourniquet (a gentle band) during planned C-section to help manage placenta accreta, a condition where the placenta grows too deeply into the uterus. The goal is to improve outcomes for both mother and baby.
CairoAges 20–40 - NCT06414655Recruiting
Twin pregnancy study: tracking mothers and babies
This study follows mothers expecting twins from early pregnancy through delivery. It helps doctors learn more about caring for twin pregnancies and their babies in China.
Hefei, AnhuiAges 18–45 - NCT06867874Recruiting
Placental particles in placenta previa and accreta
This study looks at tiny particles released by the placenta in pregnant women with placenta previa or accreta spectrum. It aims to understand how these particles might help diagnose or manage these conditions.
RomaAges 18 years+ - NCT07025954Recruiting
Delivery at 36 vs. 37 weeks for placenta previa with accreta
This trial compares delivering at 36 weeks versus 37 weeks for pregnant women with a condition called placenta previa with accreta, where the placenta covers the cervix and grows too deeply into the womb. The goal is to find the best time for delivery to improve safety for both mother and baby.
Guangzhou, GuangdongAges 18–45 - NCT04328532Recruiting
MRI check for abnormal placenta attachment risk
This study uses an MRI scan during late pregnancy to look for signs that the placenta may be abnormally attached. The goal is to help doctors plan safer care before birth, especially for people with higher-risk pregnancy features.
Vandœuvre-lès-NancyAges 18 years+ - NCT04400084Recruiting
Testing how medicines move across the placenta
This trial studies how certain drugs pass from the mother to the baby through the placenta. You may be able to help researchers understand drug safety and transfer during late pregnancy.
ParisAges 18 years+ - NCT07250412Enrolling by invitation
3D ultrasound to check placenta invasion depth in pregnancy
This trial tests if a special 3D color ultrasound can accurately detect how deeply the placenta has grown into the uterus (placenta accreta spectrum). It may help doctors plan safer deliveries for women with certain risk factors.
SohagAges 16–45 - NCT07667777Recruiting
Cervical pessary for reducing bleeding in placenta previa
This study tests whether a silicone cervical pessary can help reduce bleeding in pregnant women with placenta previa (a low-lying placenta near the cervix). You may qualify if you are between 20 and 30 weeks pregnant and have been diagnosed with this condition.
Hamburg-NordAges 18–45 - NCT04866888Recruiting
Watch outcomes after saving the uterus in placenta accreta
This trial studies what happens after a planned C-section when placenta accreta spectrum is diagnosed by ultrasound and the uterus is kept. It may help doctors understand the safest way to manage this condition and what outcomes to expect.
Alexandria, Alexandria GovernorateAges 20–40 - NCT05802251Recruiting
Ultrasound measurements to predict bleeding risk in placenta previa
This study uses special ultrasound measurements to estimate the chance of bleeding before delivery in people who have placenta previa but no symptoms. The goal is to help clinicians better predict risk and plan care.
CairoAges Any age - NCT05922397Recruiting
Using imaging to plan surgery for placenta complications
This study looks at placenta accreta spectrum (a serious placenta problem) using ultrasound or MRI images. It may help by classifying the condition in a more detailed way so surgeons can plan the right operation during surgery.
CaliAges 18–55 - NCT06185894Recruiting
New surgical technique for placenta accreta with tourniquet
This trial tests a new surgical technique for women with placenta accreta (a condition where the placenta grows too deeply into the uterus). The technique uses a special band (tourniquet) to reduce bleeding during surgery, compared to the standard approach. If you have had a C-section before and want to keep your uterus for future children, this study may be an option for you.
CairoAges 20–40 - NCT06352970Recruiting
TB infection and placenta function study
This study looks at how tuberculosis (TB) infection might affect the placenta and its function during pregnancy. If you are pregnant and giving birth soon, researchers want to learn if TB changes how the placenta grows and works.
Addis AbabaAges 18 years+ - NCT06465836Recruiting
Simpler care for placenta attachment problems in pregnancy
This trial studies a simpler, non-surgical approach to managing a condition called morbidly adherent placenta (where the placenta grows too deeply into the uterus). It is for people who are at least 28 weeks pregnant, have placenta previa, and are not having heavy bleeding.
CairoAges 25–45 - NCT06512181Recruiting
Trial for keeping the uterus during placenta accreta treatment
This trial tests a different way to manage placenta accreta that avoids removing the uterus (hysterectomy). It is for pregnant people who want to keep their uterus and would otherwise need a hysterectomy during childbirth.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07283042Recruiting
Studying a new way to classify placenta conditions
This trial tests a new classification system for placenta accreta spectrum (PAS), a condition where the placenta grows too deeply into the uterine wall. It aims to see if this system helps predict outcomes and improve care for pregnant people who need surgery for PAS.
Los Angeles, CaliforniaAges 18–55 - NCT07520201Recruiting
Comparing three surgical approaches for placenta accreta spectrum
This study compares three different surgical methods to safely treat placenta accreta spectrum, a condition where the placenta grows too deeply into the uterus. The goal is to find which approach works best with fewer complications.
AsyutAges Any age - NCT07635758RecruitingPhase 1/Phase 2
Stem Cell Treatment for Recent Stroke Recovery
This trial tests whether special cells from human placenta can help your brain recover after a recent stroke. The treatment is given as an injection and aims to reduce long-term disability.
BeijingAges 18–80 - NCT07643090Recruiting
AI ultrasound test for placenta attachment complications
This study tests a new artificial-intelligence tool that analyzes ultrasound images to detect placenta accreta spectrum—a condition where the placenta attaches too deeply to the uterus. If you're pregnant with risk factors like placenta previa (placenta covering the cervix), this trial may help doctors catch the problem earlier.
Guangzhou, GuangdongAges 18–45 - NCT07230340Enrolling by invitationPhase 4
Placenta tissue for nonhealing leg ulcers
This study tests a special dehydrated human placenta tissue dressing for leg ulcers that won't heal. You will get either standard wound care plus this dressing, or standard care alone; later you may have the chance to receive the dressing.
Rocky Mount, North CarolinaAges 18 years+ - NCT03981653Recruiting
Placenta study around normal third-trimester pregnancy
This study looks at how the placenta is working in pregnancies that are planned for cesarean delivery after at least 37 weeks. Researchers compare different pregnancy situations (including some common complications) and check placenta function to better understand placental health.
CréteilAges 18 years+ - NCT03762512Recruiting
Donate placenta after C-section for mitochondrial research and future therapies
This study collects donated placenta after a planned C-section to isolate mitochondria (the cell’s energy parts) for research and possible future therapies. Participation mainly involves being a medically healthy pregnant person who meets specific health and medication safety checks.
Ramat GanAges 18–45
Hear when a new Placenta trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placenta?
- Yes. Clin2 currently lists 46 recruiting placenta studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placenta trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placenta trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.